Mr Read first noticed a severe headache last December and, two weeks later, his face dropped on one side.
He had surgery shortly after his diagnosis to remove as much of the tumour as possible, followed by radiotherapy and chemotherapy.
In July, doctors found the tumour was growing again and he was offered a place on the new CITADEL-123 trial at UCLH.
“I was fully expecting the tumour to return due to its aggressive nature. I know the outcome isn’t great and I was happy to explore anything else,” he said.
“I’m not frightened by any of this. We are all dealt a hand of cards and you don’t know which ones you are going to get.
“It will be wonderful if this treatment helps me and if it doesn’t, it doesn’t… it may benefit someone else down the line.”
In the frontline village of Bezruky which sits in the Kharkiv region – just half…
Israelis in the West Bank are still subject to Israel's civilian law and enjoy widespread…
The announcement has, so far, been met with little enthusiasm in Gaza, though some people…
There are many reasons why it might not work. At the same time, it is…
Dr Xand van Tulleken and Professor Sunita Sar explore why we follow advice we suspect…
What you need to knowIsraeli hostilities and demolitions continued in southern Lebanon, where at least…